A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to ... flu significantly reduced the growth of the coronavirus in a recent study on animals.

Covid spreads the same way that other ... Here’s how it would work: A nasal mRNA vaccine would be taken as a spray through the nose, coating the nasal passages. The cells in the nasal lining ...

After its sudden rise and precipitous fall during the COVID-19 pandemic ... in the U.S. and Canada to Kloxxado, an emergency nasal spray for opioid overdose, from Hikma Pharmaceuticals.

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant depression. This marks a s ...